Sujun Gao

2.2k total citations
96 papers, 1.0k citations indexed

About

Sujun Gao is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Sujun Gao has authored 96 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 33 papers in Molecular Biology and 32 papers in Genetics. Recurrent topics in Sujun Gao's work include Acute Myeloid Leukemia Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Sujun Gao is often cited by papers focused on Acute Myeloid Leukemia Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Sujun Gao collaborates with scholars based in China, United States and Switzerland. Sujun Gao's co-authors include Long Su, Yehui Tan, Jintong Chen, Siqing Wang, Yuxue Jiang, Qing Yi, Yinghua Zhao, Jiuwei Cui, Keshu Zhou and Haiyi Guo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sujun Gao

86 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sujun Gao China 18 427 357 283 279 217 96 1.0k
Francesca Cottini United States 15 321 0.8× 616 1.7× 174 0.6× 153 0.5× 283 1.3× 59 1.1k
Saeid Shahrabi Iran 17 273 0.6× 323 0.9× 212 0.7× 152 0.5× 156 0.7× 49 872
Ann Janssens Belgium 20 421 1.0× 332 0.9× 603 2.1× 289 1.0× 322 1.5× 100 1.5k
Greg Ball United States 13 413 1.0× 235 0.7× 306 1.1× 121 0.4× 112 0.5× 34 861
Nicole D. Vincelette United States 15 185 0.4× 367 1.0× 155 0.5× 152 0.5× 334 1.5× 30 839
Kazuei Ogawa Japan 15 177 0.4× 536 1.5× 93 0.3× 216 0.8× 112 0.5× 68 1.1k
Alexandra Mazharian United Kingdom 21 717 1.7× 433 1.2× 281 1.0× 282 1.0× 135 0.6× 33 1.3k
Hai Zhou China 19 539 1.3× 178 0.5× 141 0.5× 149 0.5× 55 0.3× 49 917
Jingyan Xu China 18 141 0.3× 311 0.9× 102 0.4× 81 0.3× 203 0.9× 79 845
Sonja Mandl–Weber Germany 16 241 0.6× 511 1.4× 117 0.4× 77 0.3× 225 1.0× 26 921

Countries citing papers authored by Sujun Gao

Since Specialization
Citations

This map shows the geographic impact of Sujun Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujun Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujun Gao more than expected).

Fields of papers citing papers by Sujun Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujun Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujun Gao. The network helps show where Sujun Gao may publish in the future.

Co-authorship network of co-authors of Sujun Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Sujun Gao. A scholar is included among the top collaborators of Sujun Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujun Gao. Sujun Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Mingwei, et al.. (2025). Incidence and mortality related risk factors in patients with severe traumatic brain injury: A meta‑analysis. Experimental and Therapeutic Medicine. 29(4). 1–21. 1 indexed citations
3.
Chang, Chunkang, Min Zhang, Sujun Gao, et al.. (2024). Rovadicitinib in Patients with Myelofibrosis Who Were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single Arm, Multicenter, Open-Label, Phase Ib Study. Blood. 144(Supplement 1). 484–484. 1 indexed citations
4.
Sun, Chao, et al.. (2024). Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis. Frontiers in Pharmacology. 15. 1441785–1441785. 2 indexed citations
5.
Yang, Wei, Sujun Gao, Xiaojing Yan, et al.. (2024). Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6510–6510.
6.
Mo, Xiao‐Dong, He Huang, Feng Chen, et al.. (2024). A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment. Blood. 144(Supplement 1). 99–99. 1 indexed citations
7.
8.
9.
Tong, Hongyan, Sujun Gao, Wei Yang, et al.. (2023). Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML). Blood. 142(Supplement 1). 1859–1859. 4 indexed citations
10.
Gao, Sujun, et al.. (2023). [Three cases of occupational acute trimethyltin chloride poisoning].. PubMed. 41(7). 546–549. 3 indexed citations
11.
Sun, Jingnan, et al.. (2023). Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. International Journal of Biological Sciences. 20(1). 175–181. 14 indexed citations
12.
Carlo‐Stella, Carmelo, Michael Chung, Heidi Móciková, et al.. (2023). LOTIS‐5, AN ONGOING PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE WITH RITUXIMAB (LONCA‐R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL. Hematological Oncology. 41(S2). 850–851. 2 indexed citations
13.
Zhang, Jian, Sujun Gao, X. Li, et al.. (2023). 659MO Preliminary results from a phase I/II study of 9MW2821, an antibody-drug conjugate targeting nectin-4, in patients with advanced solid tumors. Annals of Oncology. 34. S464–S464. 2 indexed citations
14.
Wang, Cong, Qiuju Liu, Yuying Li, et al.. (2023). Impact of iron overload in hematopoietic stem cell transplantation. Transplant Immunology. 78. 101820–101820. 3 indexed citations
15.
Zhao, Xin, Guangsheng He, Hong Chang, et al.. (2022). Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study. Annals of Hematology. 101(12). 2611–2616. 5 indexed citations
16.
Su, Long, Jun Zou, Sujun Gao, et al.. (2021). Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD. Cellular and Molecular Immunology. 18(11). 2541–2553. 9 indexed citations
17.
18.
Song, Yuqin, Keshu Zhou, Dehui Zou, et al.. (2020). Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase. Clinical Cancer Research. 26(16). 4216–4224. 111 indexed citations
19.
20.
Liu, Ning, Yuxue Jiang, Jintong Chen, et al.. (2018). IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells. Cellular and Molecular Immunology. 16(7). 644–651. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Cottini Breakdown of academic impact, for papers by Saeid Shahrabi Breakdown of academic impact, for papers by Ann Janssens Breakdown of academic impact, for papers by Greg Ball Breakdown of academic impact, for papers by Nicole D. Vincelette Breakdown of academic impact, for papers by Kazuei Ogawa Breakdown of academic impact, for papers by Alexandra Mazharian Breakdown of academic impact, for papers by Hai Zhou Breakdown of academic impact, for papers by Jingyan Xu Breakdown of academic impact, for papers by Sonja Mandl–Weber
Rankless by CCL
2026